桑杞清眩颗粒治疗高血压患者的临床特点及中医证素分布

doi:10.20047/j.issn1673-7210.2022.32.27

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (914 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the clinical characteristics and distribution of traditional Chinese medicine syndrome elements of patients with hypertension treated by Sangqi Qingxuan Granules. Methods From January 2018 to December 2019, a total of 150 hypertensive patients who were treated with Sangqi Qingxuan Granules by Professor Huang Li in China-Japan Friendship Hospital were selected for the collection of clinical general data and syndrome element evaluation. The distribution of symptoms, tongue and pulse, syndrome elements were observed. Results A total of 150 questionnaires were distributed and 122 valid questionnaires were collected. The gender distribution of the population was mostly male (62 cases, accounting for 50.8%), the age distribution was mostly patients under 60 years old (78 cases, 63.93%), the body weight was more obese (54 cases, accounting for 44.26%), and the hypertension grade was more common in grade 1 (74 cases, accounting for 60.66%). In terms of traditional Chinese medicine syndromes, dizziness, headache, poor sleep, more dreams and dry stools were the most common symptoms. The patients were mostly characterized by pink tongue, thin fur, stringy and thready pulse, and syndrome of hyperactivity of yang. Cluster analysis showed three patterns of combination of syndrome elements: hyperactivity of yang; yin deficiency; blood stasis, qi deficiency, qi stagnation, phlegm, dampness, heat. Conclusion Sangqi Qingxuan Granules is effective in the treatment of grade 1 hypertension, especially for patients with syndrome of yin deficiency of liver and kidney and syndrome of upper hyperactivity of liver yang.

Key words： Sangqi Qingxuan Granules Hypertension Traditional Chinese medicine syndrome elements Upper hyperactivity of liver yang

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	REN Weiquan1 FAN Jiarong2 ZHANG Gaoyu2 HE Qing2 LIAO Jiangquan3 HUANG Li3 LI Lin3▲

Cite this article:

REN Weiquan1 FAN Jiarong2 ZHANG Gaoyu2 HE Qing2 LIAO Jiangquan3 HUANG Li3 LI Lin3▲. Clinical characteristics and distribution of traditional Chinese medicine syndrome elements of Sangqi Qingxuan Granules in treating hypertension[J]. 中国医药导报, 2022, 19(32): 117-121.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2022.32.27 OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I32/117

[1] Wang Z，Chen Z，Zhang L，et al. China Hypertension Survey Investigators. Status of Hypertension in China：Results From the China Hypertension Survey，2012-2015 [J]. Circulation，2018，137（22）：2344-2356.
[2] Chen LY，Pan CS，Wei XH，et al. Sang-qi Granula Reduces Blood Pressure and Myocardial Fibrosis by Suppressing Inflammatory Responses Associated with the Peroxisome Proliferator-Activated Receptors and Nuclear Factor κ B Protein in Spontaneously Hypertensive Rats [J]. Evid Based Complement Alternat Med，2013，2013：721729.
[3] Wu J，Li L，Li L，et al. Mechanism of SQQX Decoction’s Protective Effect on SHR： A Serum Metabolomics-Based Analysis [J]. Evid Based Complement Alternat Med，2020，2020：8856943.
[4] 吴佳芸，李玲玲，李瑞菡，等.基于网络药理学与分子对接探讨桑杞清眩颗粒治疗高脂血症的机制[J].中药新药与临床药理，2021，32（7）：969-978.
[5] 吴佳芸，李玲玲，乔佳君，等.桑杞清眩液对自发性高血压大鼠血清代谢组学的影响[J].中国中西医结合杂志，2021，41（4）：479-486.
[6] 朱晓星.衷敬柏教授治疗高血压经验挖掘与数据分析[D].北京：中国中医科学院，2020. DOI：10.27658/d.cnki.gzzyy.2020.000095.
[7] 朱文锋.证素辨证学[M].北京：人民卫生出版社，2008.
[8] 中国高血压防治指南修订委员会，高血压联盟（中国），中华医学会心血管病学分会，等.中国高血压防治指南（2018年修订版）[J].中国心血管杂志，2019，24（1）：24- 56.
[9] 钱超尘.黄帝内经素问[M].北京：人民卫生出版社，1998： 11.
[10] 雷骏轩，黄帆，赵思怡，等.眩晕在古文献中的认识及辨证论治[J].湖北中医杂志，2019，41（5）：63-66.
[11] 中华中医药学会心血管病分会.高血压中医诊疗专家共识[J].中国实验方剂学杂志，2019，25（15）：217-221.
[12] 赵冬.中国成人高血压流行病学现状[J].中国心血管杂志，2020，25（6）：513-515.
[13] 林洁锋，张丽华，林斌.高血压病中医体质遗传的流行病学研究[J].中国处方药，2021，19（12）：126-128.
[14] 李冠儒，李迪.我国高血压病流行病学特点及治疗展望[J].黑龙江医药，2017，30（5）：994-995.
[15] 方显明，金泽，桑博默.原发性高血压病中医证型及其相关因素的临床资料分析[J].广西中医药，2010，33（6）：15-17.
[16] 中国医师协会心血管内科医师分会双心学组，中华医学会心血管病学分会高血压学组.成年人精神压力相关高血压诊疗专家共识[J].中华内科杂志，2021，60（8）：716-723.
[17] 王丽敏，关云琦.睡眠状况与主要慢性病患病的关系[J].中华流行病学杂志，2020，41（8）：1237-1241.
[18] 张琪，任茂佳，宋晓鹏，等.高血压与焦虑抑郁共病的研究进展[J].心血管病学进展，2020，41（3）：288-291.
[19] 张磊，刘迎迎，于杰，等.高血压痰瘀互结证证治源流及本质探析[J].世界中医药，2021，16（10）：1561-1566.
[20] 简维雄，陈偶英，谭元生，等.基于高血压病中医药现代文献证型、病机特征研究[J].中华中医药学刊，2015，33（12）：2871-2874.
[21] 薛博瑜.中医内科学[M].3版.北京.人民卫生出版社，2016.
[22] 李艳君.桑杞清眩颗粒治疗原发性高血压及对血管内皮功能影响的临床观察[D].北京：北京中医药大学，2015.
[23] 巫朝银，陈桐楷，王奇.葛根素制剂的研究进展[J].世界中医药，2020，15（14）：2188-2192.
[24] 李琳，王泰龄，潘琳，等.降压脉净液对自发性高血压大鼠炎性因子及左室重构的影响[J].微循环学杂志，2010， 20（2）：65.
[25] 谭元生，黄露.高血压病中医证型与证素分布规律的文献研究[J].中华中医药学刊，2015，33（11）：2570- 2573.
[26] 于雷，陈重，刘纳文，等.350例单纯舒张期高血压患者中医证素特征分析[J].中国慢性病预防与控制，2022，30（3）：221-223.